NCT04614597View on ClinicalTrials.gov

A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China

CompletedOBSERVATIONAL
Enrollment

774

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

December 21, 2021

Study Completion Date

December 21, 2021

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Sabin strain inactivated polio vaccine

Sabin IPVs have been given to participants in previously study, blood specimens will be collected once all the subjects reach the age of 18months.

Trial Locations (1)

Unknown

Shandong Center for Disease Control and Prevention, Jinan

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

Shandong Province Centers for Disease Control and Prevention

OTHER

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT04614597 - A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China | Biotech Hunter | Biotech Hunter